sorrento therapeutics inc
(SRNE:Consolidated Issue listed on NASDAQ Capital Market)
Michael Scott Salka
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Science Committee, Sorrento Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Mr. Michael Scott Salka has been the Chief Executive Officer at AmpliPhi Biosciences Corporation since May 18, 2015. Mr. Salka serves as the Chief Executive Officer of Aspyrian, CendR, and Vesper Biologics, all biotechnology companies. He served as the Chief Executive Officer of Ambit Biosciences Corporation from 2001 to 2010. He Co-Founded Sequana Therapeutics, Inc. in early 1993. He served as the Chief Financial Officer of Sequana Therapeutics Inc. since September ...
6042 Cornerstone Ct. WestPhone: 858-210-3700
San Diego, California 92121
Board Members Memberships*
Former Chief Executive Officer and Director
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Science Committee
Carnegie Mellon University
San Diego State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|